As predicted, Prof Miles Prince is on track with getting...

As predicted, Prof Miles Prince is on track with getting underway in regard to the Clinical Sites for the PTX100 Phase 2a study. l am also very excited about the new CMO Dr Marissa Lim she has a wealth of experience and it is impeccable timing for her to be on board, it appears that James Mc Donnell and the board are forming a strong team to move forward. Also l am pleased that Epworth Freemasons are handling the first Clinical Trial as their Haematology Unit is one of the best in Australia, and l am keen to see the results from the USA and Europe's Clinicals Study. l hope many lives are saved by this amazing treatment and secondly l hope that genuine shareholders are rewarded in time.